---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-103813"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T01:02:39.834686+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics closes $2.5M public offering of shares and warrants

## Summary
- Aggregate gross proceeds of approximately $2.5 million from offering of common shares and warrants.
- Pricing at $1.75 per share and accompanying warrant; warrants exercisable at $2.00 per share for five years.
- Post-offering outstanding shares: 2,272,462; proceeds for working capital, R&D, and manufacturing scale-up.
- A.G.P./Alliance Global Partners served as placement agent with 7% fee plus expense reimbursement.

## SEC filing metadata
- accession: 0001104659-24-103813
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/0001104659-24-103813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465924103813/tm2425109d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-103813
- JSON: https://secwatch.observer/filing/0001104659-24-103813.json
- Plain text: https://secwatch.observer/filing/0001104659-24-103813.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.